Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

Podcasts
Stewart Layhe, Supply Chain Program Manager at Denver Health, compares benefits and downsides of perpetual and periodic automatic replenishment (PA
Podcasts
In this informational session, Karen Conway discusses her research with the FDA on value and the UDI.
Podcasts
Stop running out of supplies in your ORs, nursing and procedural areas and learn how to optimize your PAR levels.
Podcasts
Hear a general approach to network supply chain assessment to identify areas for improvement.
Podcasts
Having conversations with clinicians can be difficult, Howard Mann, a 30 year supply chain professional, discusses how to prepare for physician con
On-Demand Educational Webinars
Management of inventory turns, reducing waste due to product expiration, and reducing inventory reconciliation adjustments are all possible thanks to…